SECsense Logo

Karyopharm Therapeutics Inc. 8-K Report: Key Updates as of January 2, 2025

$KPTI
Form 8-K
Filed on: 2025-01-02
Source
Karyopharm Therapeutics Inc. 8-K Report: Key Updates as of January 2, 2025

Based on the provided XML section of the financial report, here are the key extracted details:

  1. Entity Information:
  • Company Name: Karyopharm Therapeutics Inc.
  • CIK: 0001503802
  • SEC File Number: 001-36167
  • EIN: 26-3931704
  • Address: 85 Wells Avenue, 2nd Floor, Newton, MA 02459
  • Phone Number: (617) 658-0600
  1. Filing Details:
  • Form Type: 8-K
  • Filing Date: January 2, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.0001
  • Stock Symbol: KPTI
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: January 2, 2025
  • End Date: January 2, 2025

Insights:

  • The filing appears to be a current report (8-K) which typically provides information on significant events or changes that may be of interest to shareholders and investors.
  • The report is dated for the start and end of the same day, suggesting it may pertain to an event that occurred on January 2, 2025.
  • The company operates within the biotechnology sector, as inferred from its name, which may be relevant for investors looking for insights into developments such as drug approvals, partnerships, or financial results.

This summary encapsulates crucial information for stakeholders looking to understand the context of Karyopharm Therapeutics Inc.'s recent developments as of the filing date.